1. 1.24. What is the statistic data of MEBT/MEBO application status in China and abroad?
    • 2010/10/15 14:32:57
    According to the large-sample statistics of National Medical Treatment website, patients treated by MEBT/MEBO accounts to 60% of the total patients In China. There are about 10000 hospitals applying MEBT/MEBO as a routine therapy to treat approximately 400,000 burn patients each year.
    MEBT/MEBO has been permitted and introduced into 30 countries as formal drug and technique such as Korea, U.A.E., Philippines and Indonesia, etc. According to the preliminary statistics, over 300 professional journals have published more than 1600 academic papers on the application of MEBT/MEBO in treating 80 types of dermatosis from 1988 to 2004, and approximately 40 million people benefited from MEBT/MEBO.
    According to the large-sample statistics, the total cure rate of MEBT/MEBO reaches to 99.42%; the cure rate of burns with TBSA more than 50% is 94.2% and TBSA more than 90% is 89%; Disability rate is less than 2.05% and total mortality rate within 16 years is only 0.58%[47].